F
Fantasy VCFantasy VCSign in
DiscoverMarketsPortfolioActivity
F
Fantasy VCCommunity is the asset
Fantasy VC
DiscoverMarketsPortfolioActivity
SettingsHow it works
Sign in
F
Fantasy VCFantasy VC
DiscoverMarketsPortfolioActivity
Sign in
F
Fantasy VCFantasy VCSign in
Markets
SK

Sri Kosuri

UCLAOctant
@srikosuri19K followersBerkeley, CA

Co-founder and CEO of Octant, a synthetic-biology drug discovery company mapping the entire universe of human receptors with engineered cells.

Co-founder and CEO of Octant, a synthetic-biology drug discovery company mapping the entire universe of human receptors with engineered cells.

Price
$22.37
▼-70.42%today
Last raised$30M·Series A·May 2026
Newstaller pin = bigger storyTap a pin to see headlines + price impact
Volume 24h
$141.4K
Holders
3,720
7d change
-70.42%

News

·12
+0.05
UT
Digital Music Gets Genetic – Utne
utne.com · 576d ago
LI
NZ - AU : Kharmagtai Maiden Ore Reserve , Updated Mineral Resource
livenews.co.nz · 587d ago

Recent trades

·0
No recent trades.

Career

  1. 2017–present
    Co-Founder & CEO · Octant
    Polypharmacology drug discovery engine for complex diseases.
  2. 2014–present
    Associate Professor · UCLA
    Runs Kosuri Lab on functional genomics and synthetic biology.
  3. 2010–2014
    Researcher · Wyss Institute, Harvard
    Built tech in gene synthesis, DNA storage, and multiplexed assays.
  4. 2007–2010
    First Employee · Joule Unlimited
    Engineered algae-to-biofuel platform at Flagship-backed startup.

About

Sri Kosuri is co-founder and CEO of Octant, the Emeryville synthetic-biology company designing multi-target drugs for complex diseases like obesity, diabetes, and cardiovascular conditions.

Accomplishments

  • Co-founder and CEO of Octant, synthetic-biology drug-discovery company
  • Raised $30M Series A from Andreessen Horowitz, 8VC, SV Angel, and Allen & Co
  • Associate Professor of Chemistry and Biochemistry at UCLA
  • First employee at Joule Unlimited; SAB member at Gen9 gene-synthesis company
  • Built foundational tech in DNA storage, gene synthesis, and multiplexed assays at Wyss/Harvard

Pricing breakdown

Accomplishments23 · 35%
Funding · $30M raised
Mainstream popularity22 · 25%
Social popularity31 · 25%
X · 19K followers · 1.9 tweets/day · verified
Net worth36 · 15%
Composite
27/100
Intrinsic
$22.37
Market
+0.00%

Intrinsic price is set by the four-factor fundamentals score (35/25/25/15). Market price floats around it via a constant-product AMM — every trade moves the curve.

Tags

biohealthai